Introduction
Transition from Clinical Trials to RWE in Psoriasis & Step into Possibility in Alopecia Areata
Objectives
1. Discuss how real-world experience shapes clinical practice and informs practical treatment decision-making.
2. Highlight how real-world experiences with ixekizumab in patients with plaque psoriasis (PsO) compare with data from randomized controlled trials, and address knowledge gaps
3. Highlight how real-world experiences with
baricitinib in patients with Alopecia Areata (AA) compare with data from randomized controlled trials, and address knowledge gaps
This Course For :
Physician
( Dermatology , Hematology , Rheumatology )
Resident / Fellow
( Dermatology , Hematology , Rheumatology )
Clinical Pharmacy
Pharmacy
Speaker
Dr. Awadh Alamri
Assistant Professor and Consultant Dermatologist
Section Head of Dermatology, National Guard Hospital- Jeddah, Saudi Arabia
Dr. Abdulhadi Aljfri
Assistant professor of dermatology
Consultant dermatologist
King Abdulaziz medical city (NGH), Jeddah
Dr. Yousef Binamer
MD,EMBA,FRCPC,DABD,FAAD
Chairman, Department of Dermatology at King Faisal Specialist Hospital and Research Centre, Riyadh
Provided by :
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
10 Dec 2025 To 10 Dec 2025 -
09:00 PM To 10:00 PM 
Certificate Available 
Online
- 10
Add to Calendar
12/10/2025 09:00 PM
12/10/2025 10:00 PM
Asia/ Riyadh
Transition from Clinical Trials to RWE in Psoriasis & Step into Possibility in Alopecia Areata
Transition from Clinical Trials to RWE in Psoriasis & Step into Possibility in Alopecia Areata
https://medicalacademy.org/portal/event/view/2499
